Pulse - Value Added
← Library
Knowledge Library · Tools
Powered by Pulse — Value Added. The #1 source of truth in revenue operations. Find the bottleneck. Fix the pipeline. Win the quarter.

What KPIs should a fractional CRO own at a medical device company in 2027?

Curated by · Fractional CRO · Maryland
PULSEKNOWLEDGE LIBRARY
pulserevops.com

Quality
Certified
Pulse ToolsWhat KPIs should a fractional CRO own at a medical device company in 2027?
📖 745 words🗓️ Published Sep 23, 2026
Direct Answer

A fractional Chief Revenue Officer (CRO) at a medical device company should own 5-7 core KPIs that bridge clinical validation with commercial execution. The most critical metrics are:

  1. Qualified pipeline creation rate – New opportunities meeting strict criteria (surgeon commitment, hospital budget approval, GPO contract slot)
  2. Clinical evaluation-to-purchase conversion time – Days from trial agreement to first purchase order
  3. Average deal size by product line – Segmented for capital equipment ($50K–$500K+), consumables ($5K–$50K annual), and diagnostics
  4. Net revenue retention (NRR) – For recurring revenue streams (service contracts, consumable refills, software)
  5. Sales cycle length by buyer persona – Segmented by surgeon, hospital administrator, and GPO
  6. Win rate per territory – Tracked by region and channel (direct vs. distributor)
  7. Channel partner sourced revenue – Percentage of revenue through distributors vs. direct sales
What KPIs should a fractional CRO own at a medical device company in 2027 — figure 1

The fractional CRO should report these in a single-page dashboard with weekly leading indicators and monthly lagging metrics. This role typically costs a retainer for 10-20 days per month and is best suited for companies from pre-revenue to approximately $5M ARR.

FAQ

What is the minimum data quality needed for a fractional CRO to be effective? You need a CRM with at least 6 months of historical deal data, including stage names, close dates, and deal values. If your CRM is empty or contains junk data, expect the CRO to spend 2-4 weeks cleaning it before reporting KPIs. The first month will be diagnostic, not strategic.

How many KPIs should a fractional CRO own at once? Five to seven. More than that and you lose focus. The CRO should pick one or two "north star" KPIs (e.g., clinical evaluation conversion time) and keep the rest as supporting metrics. The CEO should be able to recite the top three KPIs from memory after one month.

Can a fractional CRO own revenue operations (RevOps) KPIs too? Yes, but only if they have RevOps experience. Many fractional CROs come from sales leadership, not operations. If you need CRM automation, lead scoring, or reporting infrastructure, consider hiring a fractional RevOps lead separately or ask the CRO to recommend one. Do not assume a CRO can build a Salesforce instance from scratch.

What happens if the fractional CRO misses their KPI targets for two months? First, examine whether the targets were realistic given market conditions (e.g., a recession in hospital capital spending). Second, check if the CRO has the resources they need (e.g., budget for a sales development rep). If the CRO is not diagnosing the root cause or adjusting the plan, it is time to replace them. A good fractional CRO will flag a miss within two weeks, not two months.

What is the difference between a fractional CRO and a full-time VP of Sales in medical device? A fractional CRO (10-20 days/month) costs a retainer plus small equity (0.5-2%), focuses on pipeline velocity and trial conversion, and is best for pre-revenue to $5M ARR. A full-time VP of Sales ($200K-$300K salary plus bonus and benefits) owns full P&L, headcount management, and quota setting, and is best for companies with $5M+ ARR and a sales team of 5+ people.

Should a fractional CRO own FDA-related KPIs? No. Things like FDA approval timelines, hospital budget cycles, and GPO contract windows are external constraints. The CRO should own how the sales team responds to these constraints, not the constraints themselves. If your product is still awaiting 510(k) clearance, the CRO's KPI should be "number of surgeon commitments secured" – not revenue.

Sources

flowchart TD S["What KPIs should a fractional CRO own "] S --> N0["Assess"] N0 --> N1["Plan"] N1 --> N2["Build"] N2 --> N3["Measure"] N3 --> N4["Improve"]
flowchart LR C["What KPIs should a fractional CRO own "] C --> H0["Assess"] C --> H1["Plan"] C --> H2["Build"] C --> H3["Measure"] C --> H4["Improve"]

Related on PULSE

Download:
Was this helpful?  
This page will be disappearing soon.
Download the whole page as a PDF to keep — just $1.
⌬ Apply this in PULSE
Gross Profit CalculatorModel margin per deal, per rep, per territory